Mark Cuban discusses his approach to fixing healthcare, emphasizing transparency in drug pricing and the need to dismantle the influence of pharmacy benefit managers. He advocates for cash pricing legislation and supports the Break Up Big Medicine Act to separate insurance companies from their non-insurance interests.

Mark Cuban and Optum CEO Patrick Conway engaged in a heated discussion about drug prices and pharmacy benefit managers, highlighting their differing views on how to reform the healthcare system. Cuban argued for breaking up large insurance companies and criticized the lack of transparency in PBM contracts, while Conway emphasized the need to tackle high hospital and pharmaceutical costs. Both acknowledged the other's contributions but remained divided on the root causes of high drug prices and solutions.